---
layout: post
title: "Statement of Organization, Functions, and Delegations of Authority"
date: 2026-02-05 19:01:45 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-26280
original_published: 2022-12-02 00:00:00 +0000
significance: 8.00
---

# Statement of Organization, Functions, and Delegations of Authority

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** December 02, 2022 00:00 UTC
**Document Number:** 2022-26280

## Summary

The Secretary of Health and Human Services delegates to the National Institutes of Health (NIH) Director and the Food and Drug Administration (FDA) Commissioner the authorities vested in the Secretary of Health and Human Services under Section 3 of the Accelerating Access to Critical Therapies for ALS Act, as amended, to establish and implement a Public-Private Partnership for rare neurodegenerative diseases. These authorities may be redelegated. Exercise of this authority shall be in accordance with established policies, procedures, guidelines, and regulations as prescribed by the Secretary. The Secretary retains the authority to submit reports to Congress and promulgate regulations.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/12/02/2022-26280/statement-of-organization-functions-and-delegations-of-authority)
- API: https://www.federalregister.gov/api/v1/documents/2022-26280

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
